TJP1 and neoplasm: TJP1 acts in two signaling pathways related to adherent unions and gap junctions [29] and contributes to cell proliferation in leiomyosarcoma by favoring cell–cell aggregation and cytokine-mediated communication in the tumor microenvironment [48].